Chemoinformaics analysis of Methyl 2,4-dihydroxybenzoate
| Molecular Weight | 168.148 | nRot | 1 |
| Heavy Atom Molecular Weight | 160.084 | nRig | 7 |
| Exact Molecular Weight | 168.042 | nRing | 1 |
| Solubility: LogS | -1.636 | nHRing | 0 |
| Solubility: LogP | 1.928 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 21.9023 |
| nHD | 2 | BPOL | 10.6297 |
| QED | 0.611 |
| Synth | 1.777 |
| Natural Product Likeliness | 0.592 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.007 |
| HIA | 0.009 |
| CACO-2 | -4.603 |
| MDCK | 0.0000144 |
| BBB | 0.243 |
| PPB | 0.82365 |
| VDSS | 0.772 |
| FU | 0.188906 |
| CYP1A2-inh | 0.93 |
| CYP1A2-sub | 0.8 |
| CYP2c19-inh | 0.323 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.257 |
| CYP2c9-sub | 0.92 |
| CYP2d6-inh | 0.381 |
| CYP2d6-sub | 0.605 |
| CYP3a4-inh | 0.439 |
| CYP3a4-sub | 0.17 |
| CL | 14.979 |
| T12 | 0.915 |
| hERG | 0.024 |
| Ames | 0.156 |
| ROA | 0.029 |
| SkinSen | 0.327 |
| Carcinogencity | 0.047 |
| EI | 0.96 |
| Respiratory | 0.141 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.856129 |